Dihydropyridine Calcium Channel Blockers and Kidney Outcomes.

Matthew F BlumAditya SurapaneniAlexander ChangLesley A InkerTeresa K ChenLawrence J AppelJung-Im ShinMorgan E Grams

Published in: Journal of general internal medicine (2024)

DCCBs were associated with increased risk of albuminuria and, in the absence of RAS blockade, KFRT. These findings suggest coupling DCCB therapy with RAS blockade may mitigate adverse kidney outcomes.

Keyphrases

wild type
type diabetes
emergency department
metabolic syndrome
skeletal muscle
bone marrow
weight loss
insulin resistance
glycemic control